NCT04871815View on ClinicalTrials.gov

Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers.

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

April 27, 2021

Primary Completion Date

March 7, 2022

Study Completion Date

March 7, 2022

Conditions
Long COVID
Interventions
DRUG

sodium pyruvate nasal spray

Subjects will use a sodium pyruvate nasal spray 3x daily for 7 days.

Trial Locations (1)

65897

Missouri State University, Springfield

Sponsors

Collaborators (1)

Dynamic DNA Laboratories
All Listed Sponsors
collaborator

Missouri State University

OTHER

collaborator

Dynamic DNA Laboratories

INDUSTRY

collaborator

Trinity Health System

INDUSTRY

collaborator

Family First Medical Research Center

OTHER

lead

Cellular Sciences, inc.

INDUSTRY